This treatment, open label, single group assignment, safety/efficacy study will enroll approximately 20 participants. The Principal Investigator is Horst Sievert, MD from CardioVascular Center Frankfurt, St. Katharinen Hospital.
CrossBoss CTO Catheter is designed for the placement of guidewires into discrete regions of the vasculature. It utilizes interventional techniques and requires no complicated hardware.
